Prevalence and Risk Factors for Hypertension in Hemophilia

Overview

Journal Hypertension

Date 2013 May 1

PMID 23630949

Citations 17

Authors

Annette von Drygalski

Nicholas A Kolaitis

Ricki Bettencourt

Jaclyn Bergstrom

R Kruse-Jarres

Doris V Quon

Christina Wassel

Ming C Li

Jill Waalen

Darlene J Elias

Laurent O Mosnier

Matthew Allison

Affiliations

Soon will be listed here.

Abstract

Hypertension (HTN) is a major risk factor for intracranial hemorrhage. We, therefore, investigated the prevalence, treatment, and control of HTN in adult patients with hemophilia (PWH). PWH≥18 years (n=458) from 3 geographically different cohorts in the United States were evaluated retrospectively for HTN and risk factors. Results were compared with the nationally representative sample provided by the contemporary National Health and Nutrition Examination Survey (NHANES). PWH had a significantly higher prevalence of HTN compared with NHANES. Overall, the prevalence of HTN was 49.1% in PWH compared with 31.7% in NHANES. At ages 18 to 44, 45 to 64, 65 to 74, and ≥75 years, the prevalence of HTN for PWH was 31.8%, 72.6%, 89.7%, and 100.0% compared with 12.5%, 41.2%, 64.1%, and 71.7% in NHANES, respectively. Of treated hypertensive PWH, only 27.1% were controlled, compared with 47.7% in NHANES (all P<0.05). Age, body mass index, diabetes mellitus, and renal function were independently associated with HTN. Among patients with moderate or severe hemophilia there was a trend (≈1.5-fold) for higher odds of having HTN compared with patients with mild hemophilia. On the basis of these results, new care models for adult PWH and further studies for the causes of HTN in hemophilia are recommended.

Citing Articles

Long-term clinical outcomes of prophylaxis with an rFVIIIFc or rFIXFc in adults aged ≥50 years with hemophilia A or B.

Quon D, Jackson S, Alvarez-Roman M, Khan U, Casiano S, Ragni M Blood Adv. 2024; 8(18):4751-4755.

PMID: 39042888 PMC: 11414653. DOI: 10.1182/bloodadvances.2023012462.

Risk of Intracranial Hemorrhage in Persons with Hemophilia A in the United States: Real-World Retrospective Cohort Study Using the ATHNdataset.

Hu J, Chandler M, Manuel C, Caicedo J, Denne M, Ewenstein B J Blood Med. 2024; 15:191-205.

PMID: 38699197 PMC: 11063465. DOI: 10.2147/JBM.S443380.

Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis.

Liu M, Zhao Z, Lu K, Luo Q, Zhao T, Wang H J Clin Hypertens (Greenwich). 2023; 25(11):1019-1026.

PMID: 37814496 PMC: 10631100. DOI: 10.1111/jch.14730.

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia.

Tran D, Benson C, Boice J, Chitlur M, Dunn A, Escobar M Expert Rev Hematol. 2023; 16(sup1):19-37.

PMID: 36920859 PMC: 10020869. DOI: 10.1080/17474086.2023.2171981.

Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review.

Shapiro A, Hardesty B, Peyvandi F, Iorio A Res Pract Thromb Haemost. 2023; 7(1):100007.

PMID: 36891522 PMC: 9986102. DOI: 10.1016/j.rpth.2022.100007.

References

. Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group. Lancet. 1998; 352(9143):1801-7. View

Ljung R . Intracranial haemorrhage in haemophilia A and B. Br J Haematol. 2007; 140(4):378-84. DOI: 10.1111/j.1365-2141.2007.06949.x. View

Sramek A, Kriek M, Rosendaal F . Decreased mortality of ischaemic heart disease among carriers of haemophilia. Lancet. 2003; 362(9381):351-4. DOI: 10.1016/s0140-6736(03)14021-4. View

Nilsson I, Berntorp E, Lofqvist T, Pettersson H . Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med. 1992; 232(1):25-32. DOI: 10.1111/j.1365-2796.1992.tb00546.x. View

Witmer C, Presley R, Kulkarni R, Soucie J, Manno C, Raffini L . Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States. Br J Haematol. 2010; 152(2):211-6. DOI: 10.1111/j.1365-2141.2010.08469.x. View

Song Y, Sung J, Lawlor D, Davey Smith G, Shin Y, Ebrahim S . Blood pressure, haemorrhagic stroke, and ischaemic stroke: the Korean national prospective occupational cohort study. BMJ. 2004; 328(7435):324-5. PMC: 338099. DOI: 10.1136/bmj.328.7435.324. View

Giroud M, Milan C, Beuriat P, Gras P, Essayagh E, Arveux P . Incidence and survival rates during a two-year period of intracerebral and subarachnoid haemorrhages, cortical infarcts, lacunes and transient ischaemic attacks. The Stroke Registry of Dijon: 1985-1989. Int J Epidemiol. 1991; 20(4):892-9. DOI: 10.1093/ije/20.4.892. View

Levey A, Bosch J, Lewis J, Greene T, Rogers N, Roth D . A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130(6):461-70. DOI: 10.7326/0003-4819-130-6-199903160-00002. View

Aronson D . Cause of death in hemophilia A patients in the United States from 1968 to 1979. Am J Hematol. 1988; 27(1):7-12. DOI: 10.1002/ajh.2830270103. View

10.

Lewington S, Clarke R, Qizilbash N, Peto R, Collins R . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360(9349):1903-13. DOI: 10.1016/s0140-6736(02)11911-8. View

11.

Flegal K, Carroll M, Kit B, Ogden C . Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012; 307(5):491-7. DOI: 10.1001/jama.2012.39. View

12.

Fransen van de Putte D, Fischer K, Makris M, Tait R, Collins P, Meijer K . Increased prevalence of hypertension in haemophilia patients. Thromb Haemost. 2012; 108(4):750-5. DOI: 10.1160/TH12-05-0313. View

13.

Biere-Rafi S, Baarslag M, Peters M, Kruip M, Kraaijenhagen R, den Heijer M . Cardiovascular risk assessment in haemophilia patients. Thromb Haemost. 2010; 105(2):274-8. DOI: 10.1160/TH10-07-0460. View

14.

. Standards of medical care in diabetes--2010. Diabetes Care. 2010; 33 Suppl 1:S11-61. PMC: 2797382. DOI: 10.2337/dc10-S011. View

15.

Zanon E, Iorio A, Rocino A, Artoni A, Santoro R, Tagliaferri A . Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. Haemophilia. 2011; 18(1):39-45. DOI: 10.1111/j.1365-2516.2011.02611.x. View

16.

Kim H, Nam C, Jee S, Suh I . Comparison of blood pressure-associated risk of intracerebral hemorrhage and subarachnoid hemorrhage: Korea Medical Insurance Corporation study. Hypertension. 2005; 46(2):393-7. DOI: 10.1161/01.HYP.0000177118.46049.e6. View

17.

Soucie J, Nuss R, Evatt B, Abdelhak A, Cowan L, Hill H . Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. Blood. 2000; 96(2):437-42. View

18.

Kahende J, Adhikari B, Maurice E, Rock V, Malarcher A . Disparities in health care utilization by smoking status--NHANES 1999-2004. Int J Environ Res Public Health. 2009; 6(3):1095-106. PMC: 2672402. DOI: 10.3390/ijerph6031095. View

19.

Darby S, Kan S, Spooner R, Giangrande P, Hill F, Hay C . Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood. 2007; 110(3):815-25. DOI: 10.1182/blood-2006-10-050435. View

20.

Siboni S, Mannucci P, Gringeri A, Franchini M, Tagliaferri A, Ferretti M . Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost. 2009; 7(5):780-6. DOI: 10.1111/j.1538-7836.2009.03318.x. View